Management of severe hemolytic disease of the fetus and newborn due to maternal anti-Rh17: Using incompatible blood

Pediatr Blood Cancer. 2024 Nov;71(11):e31264. doi: 10.1002/pbc.31264. Epub 2024 Aug 11.

Authors

Henna Butt¹, Colleen Rich², Jennifer Webb¹

Affiliations

¹ Pediatric Hematology, Children's National Hospital, Washington, District of Columbia, USA.
² Department of Pediatrics, Children's National Hospital, Washington, District of Columbia, USA.

PMID: 39129129
DOI: 10.1002/pbc.31264

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Adult
Blood Group Incompatibility
Erythroblastosis, Fetal* / blood
Erythroblastosis, Fetal* / therapy
Female
Humans
Infant, Newborn
Pregnancy
Rh-Hr Blood-Group System / immunology

Substances

Rh-Hr Blood-Group System